crohn's disease and glp-1 The role of RA in inflammatory bowel disease. The GLP-1 RA GI and Hepatology News -

sitagliptin Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

doi: 10.5530/phrev.2020.14.13 [DOI] [Google Scholar] 15

Martins background in family medicine gives him unique insight into how weight loss medications interact with overall health

The ability to prove the severity of the injury is often the most critical in an Ozempic lawsuit settlement